NCT06655207
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
Phase: N/A
Role: Lead Sponsor
Start: Aug 6, 2025
Completion: Jul 30, 2026